Renowned Dermatologist Dr. Michael H. Gold Joins AIVITA Scientific Advisory Board
IRVINE, Calif. – September 21, 2017 – AIVITA Biomedical, a clinical research company and commercial skincare product developer, announced today that internationally-known dermatologist and cosmetic surgeon Dr. Michael H. Gold has joined its Scientific Advisory Board. Dr. Gold brings with him invaluable knowledge and expertise stemming from his accomplished career in medical and cosmetic dermatology, and will help guide the Company in its commercial skincare efforts. Dr. Gold joins other notable skincare professionals Dr. Mary Lupo, founder of the Lupo Center for Aesthetic and General Dermatology, Dr. Zoe Draelos, research and clinical dermatologist, and consumer skincare industry veteran Susan Bloomfield in this role. Dr. Gold’s addition comes as AIVITA prepares to launch its upcoming ROOT OF SKINTM line of rejuvenating skincare products.
Dr. Michael H. Gold is the founder of the Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and Tennessee Clinical Researcher Center located in Nashville, Tennessee. He is a Clinical Assistant Professor at Vanderbilt University School of Nursing and an Adjunct Assistant Professor at Meharry Medical College in Nashville, and serves as Visiting Professor of Dermatology at two prominent medical universities in China. He has earned a national and international reputation for providing patients with leading-edge technological advances and has expertise in all facets of dermatology and aesthetic care, and remains a sought-after lecturer at medical meetings worldwide.
“Dr. Gold’s extensive knowledge in medical and aesthetic skincare will be another welcome addition to our Scientific Advisory Board,” said AIVITA CEO Dr. Hans Keirstead. “We view his joining as a vote of confidence in our latest skincare advancements, which we are excited to be bringing to consumers nationwide.”
News of the Company’s skincare advancements and upcoming ROOT OF SKINTM product announcements will follow.
About AIVITA Biomedical
AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its commercial line of skin care products and therapeutic pipeline. Sales of AIVITA’s skin care products support its clinical development efforts, including a platform cancer immunotherapy.